90%+ success rates, treating leukaemia, thalassaemia, aplastic anaemia, lymphoma and sickle cell disease in adults and children across 5 dedicated centres.
Looking for a specific insurance provider? Simply use our search function or contact us for assistance and our knowledgeable team will happily verify whether your provider is accepted at our facility.
Ask about your insurance
Yes. Submit blood counts, bone marrow biopsy, HLA typing, imaging, and treatment history before booking travel. A BMT specialist returns a written eligibility assessment, treatment recommendation, and cost estimate within 48 to 72 hours. Contact the team via WhatsApp on +1 718 550 0880 or email [email protected].
Apollo's International Patient Care team handles all BMT enquiries, donor matching questions, and treatment coordination 24/7.
Services include pre-travel video consultations, written cost estimates, visa invitation letters, airport transfer, interpreter support, and telemedicine follow-up after returning home.
Apollo coordinators provide a full treatment itinerary before you travel. Telemedicine follow-up with your transplant haematologist is available once you return home.
BMT costs at Apollo vary depending on transplant type, donor source, and patient condition. As a general indication:
All figures are 60% to 80% lower than UK or US equivalents. A written estimate is provided within 48 hours of submitting your reports, with no obligation to proceed.
Apollo's BMT centres are JCI and NABH accredited, and the programme is registered with CIBMTR (USA), the international body that benchmarks transplant outcomes globally.
Overall success rates are 90%+, with autologous BMT achieving 70% to 90% and allogeneic BMT 60% to 80%, consistent with international benchmarks. The paediatric programme reports over 80% cure rates for childhood leukaemia and up to 90% for thalassaemia with matched sibling donors.
Yes. Apollo offers haploidentical transplants using a parent, child, or 50% matched sibling as the donor, meaning most patients have an available donor immediately. Unrelated matched donors are accessed through national registries for allogeneic cases. Cord blood transplant is available for paediatric patients.
Apollo has developed specific haploidentical protocols for sickle cell disease patients with strong outcomes. The transplant team initiates HLA typing and donor evaluation before you arrive.